| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 14,354 | 13,082 | 15,968 | 16,969 | | Cost of Revenue | 5,700 | 6,091 | 5,908 | 6,014 | | | Gross Profit |
-
| 6,991 | 10,060 | 10,955 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 9,512 | 7,878 | 6,653 | 6,688 | | Non Recurring |
-
|
-
|
-
| (40) | | Others | 470 | 6,593 | 3,450 | 17,956 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (7,480) | (43) | (13,649) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 10 | | Earnings Before Interest And Taxes | (1,328) | (7,480) | (43) | (13,639) | | Interest Expense | 1,795 | 1,914 | 2,213 | 2,605 | | Income Before Tax | (3,123) | (9,394) | (2,256) | (16,244) | | Income Tax Expense | (1,211) | (4,847) | (122) | (3,753) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,912) | (4,547) | (2,134) | (12,491) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,912) | (4,547) | (2,134) | (12,491) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,912) | ($4,547) | ($2,134) | ($12,491) |
|
0.51% Nasdaq 
Income Statement
